International Business News - Teva http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif The Generic Pharmaceutical Association spent $506,976 in the third quarter to lobby on issues affecting the drug industry, according to a recent disclosure form. http://www.ibtimes.com/articles/20081202/generic-drug-group-spent-506-976-lobbying-in-3q.htm Tue, 02 Dec 2008 11:19:25 EST Watson Pharmaceuticals Inc. said Wednesday it has received approval to market its generic version of the 150 mg dose of antidepressant Wellbutrin XL. Watson said the Food and Drug Administration approved its Abbreviated New Drug Application for 150 mg tablets of extended-release bupropion hydrochloride, the active ingredient in Wellbutrin XL. The company intends to begin selling the drug immediately. http://www.ibtimes.com/articles/20081126/watson-says-fda-approves-its-generic-wellbutrin-xl.htm Wed, 26 Nov 2008 16:27:36 EST Two generic drug developers said Wednesday they are challenging the patent on the extended-release muscle-relaxant Amrix, and biotechnology company Cephalon Inc. is filing a lawsuit to halt sales of the drug. http://www.ibtimes.com/articles/20081126/cephalon-sues-generic-companies-over-patents.htm Wed, 26 Nov 2008 14:06:31 EST British drugmaker AstraZeneca PLC backed its full-year profit outlook Tuesday after resolving a patent dispute with Teva Pharmaceutical Industries Ltd. http://www.ibtimes.com/articles/20081125/astrazeneca-maintains-2008-profit-forecast.htm Tue, 25 Nov 2008 16:07:22 EST Teva Pharmaceutical Industries Ltd. said Tuesday it will resume sales of the child asthma drug Pulmicort in December 2009 as part of a settlement with the drug's maker, AstraZeneca PLC. http://www.ibtimes.com/articles/20081125/teva-will-relaunch-pulmicort-in-2009-under-deal.htm Tue, 25 Nov 2008 15:53:59 EST Watson Pharmaceuticals Inc. said Tuesday it will pay $36 million for a portfolio of generic drugs from rival Teva Pharmaceutical Industries Ltd., as that company closes its buyout of Barr Pharmaceuticals Inc. http://www.ibtimes.com/articles/20081125/watson-to-buy-teva-drugs-for-36-million.htm Tue, 25 Nov 2008 08:43:43 EST AstraZeneca PLC won the first round of a legal fight over the release of a generic version of its child asthma medication Pulmicort Respules by rival Teva Pharmaceutical Industries Ltd. on Thursday as it also unveiled job cuts in Europe. http://www.ibtimes.com/articles/20081120/astrazeneca-wins-first-round-in-teva-litigation.htm Thu, 20 Nov 2008 17:37:46 EST AstraZeneca PLC said Thursday it has been granted a temporary restraining order in a U.S. court to halt the launch of a generic version of its child asthma medication Pulmicort Respules by rival Teva Pharmaceutical Industries Ltd. http://www.ibtimes.com/articles/20081120/astrazeneca-wins-first-round-in-teva-litigation.htm Thu, 20 Nov 2008 06:24:43 EST Shares of drug developer AstraZeneca fell Wednesday after the company reported mixed study results from its developing lung cancer treatment Zactima and as it faces new generic competition to its asthma drug Pulmicort. http://www.ibtimes.com/articles/20081119/astrazeneca-shares-fall-on-study-data-competition.htm Wed, 19 Nov 2008 12:15:04 EST Sanofi-Aventis SA said Wednesday it has settled lawsuits against rival drugmakers it accused of infringing on its patents in the United States with their generic versions of its allergy treatments Allegra and Nasacort. http://www.ibtimes.com/articles/20081119/sanofi-aventis-settles-patent-infringement-cases.htm Wed, 19 Nov 2008 08:56:09 EST Generic drug developer Teva Pharmaceutical Industries Ltd. said Wednesday the Food and Drug Administration approved its version of AstraZeneca's asthma treatment Pulmicort. http://www.ibtimes.com/articles/20081119/teva-gets-fda-approval-for-generic-asthma-drug.htm Wed, 19 Nov 2008 08:47:59 EST AstraZeneca PLC said Wednesday it is launching a generic version of its own child asthma medication Pulmicort Respules after U.S. regulators paved the way for its rival Teva Pharmaceutical Industries Ltd. to do the same. http://www.ibtimes.com/articles/20081119/fda-approves-generic-version-of-astra-asthma-drug.htm Wed, 19 Nov 2008 12:43:58 EST Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc. settled a patent lawsuit with Sanofi-Aventis' over allergy drugs Allegra and Nasacort, allowing sales of certain generic doses of the drugs early, the companies said Wednesday. http://www.ibtimes.com/articles/20081119/teva-barr-settle-patent-dispute-with-sanofi.htm Wed, 19 Nov 2008 07:26:37 EST A new startup company wants to have a say in the high-stakes patent disputes that loom over many industries. In the drug business, for instance, Pfizer Inc. is suing generics maker Teva Pharmaceutical Industries, accusing it of infringing on a patent covering Pfizer's top-selling cholesterol medicine. http://www.ibtimes.com/articles/20081118/online-startup-aims-to-improve-patent-quality.htm Tue, 18 Nov 2008 00:03:59 EST A new startup company wants to have a say in the high-stakes patent disputes that loom over many industries. In the drug business, for instance, Pfizer Inc. is suing generics maker Teva Pharmaceutical Industries, accusing it of infringing on a patent covering Pfizer's top-selling cholesterol medicine. http://www.ibtimes.com/articles/20081117/online-startup-aims-to-improve-patent-quality.htm Mon, 17 Nov 2008 09:14:52 EST Mylan Inc. said Monday the Food and Drug Administration tentatively approved the drug developer's generic capsule version of Wyeth's antidepressant Effexor XR. http://www.ibtimes.com/articles/20081117/mylan-gets-tentative-fda-ok-on-antidepressant.htm Mon, 17 Nov 2008 08:34:00 EST Teva Pharmaceutical Industries Inc. has asked the Food and Drug Administration to approve its generic version of Gilead Sciences Inc.'s HIV drug Truvada, Gilead said Friday. http://www.ibtimes.com/articles/20081114/gilead-says-teva-asks-for-generic-truvada-approval.htm Fri, 14 Nov 2008 18:09:20 EST Generic drugmaker Teva Pharmaceuticals Industries Ltd. said Friday an appeals court ruling will prevent the company from launching a cheaper version of the heartburn drug Prevacid before next year. http://www.ibtimes.com/articles/20081107/ruling-stops-teva-from-launching-generic-prevacid.htm Fri, 07 Nov 2008 14:58:36 EST Teva Pharmaceutical Industries Ltd. and its acquisition target Barr Pharmaceuticals demonstrated the earnings power of generic drugs Thursday amid a serious economic slowdown. http://www.ibtimes.com/articles/20081106/sector-snap-generic-drug-cos-show-strong-profits.htm Thu, 06 Nov 2008 13:54:43 EST Teva Pharmaceutical Industries Ltd. raised its full-year earnings estimate Thursday following a surge in profit during the third quarter. The Israeli manufacturer of generic drugs now expects earnings between $2.79 and $2.85 for full-year 2008, up from prior guidance of $2.69 to $2.75. The revised guidance includes an 8 cents per share impairment charge that was excluded from earlier estimates. http://www.ibtimes.com/articles/20081106/teva-boosts-full-year-earnings-outlook.htm Thu, 06 Nov 2008 12:50:13 EST